One-Year Transcatheter Left Atrial Appendage Occlusion Outcomes in the US
Researchers sought to determine the 1-year clinical outcomes in patients who receive transcatheter left atrial appendage occlusion.
Researchers sought to determine the 1-year clinical outcomes in patients who receive transcatheter left atrial appendage occlusion.
Investigators examined prevalence and long-term survival in patients with permanent pacemaker implantation who had preoperative atrial fibrillation before valve surgery.
Investigators compared the efficacy and safety of catheter ablation and antiarrhymatic medication as first-line therapy for patients with an ICD and ventricular tachycardia.
Camzyos is an oral, selective allosteric and reversible inhibitor of cardiac myosin.
The placebo-controlled, event-driven DELIVER study included 6263 patients.
A study was conducted to examine the incidence, associated characteristics, and outcomes of pericardial effusion following LAAO.
A study was conducted to compare ablation-based rhythm control with rate control and their effect on clinical outcomes in patients with atrial fibrillation and heart failure.
A study assessed the relationship between atrial fibrillation and occupational exposure in patients employed as firefighters.
Investigators conducted a study to evaluate the relationship between coffee intake and incident arrhythmia, cardiovascular disease, and mortality.
A randomized clinical trial evaluated the safety and efficacy of transcutaneous magnetic stimulation of the left stellate ganglion for patients with VT storm.